|
|
|
|
¡¡ |
|
¡¡ |
|
|
|
¡¡ |
HOME > ÇÐȸ°£Ç๰ >
¿ë¾î»çÀü |
|
Á¦¸ñ |
DNA and RT PCR apply for detection and viability of Mycobacterium leprae in Fusidic Acid treatment against in vitro infection of Mycobacterium leprae |
|
|
|
|
ÀúÀÚ |
Min Joo Kim, Se Kon Kim, Won Sang Park#, and Gue Tae Chae |
¼Ò¼Ó |
Chronic Diseases Laboratory, Dept. of Pathology#, Catholic University Medical College |
|
|
³âµµ |
1996 |
±Ç |
29 |
|
|
È£ |
2 |
¹øÈ£ |
|
|
|
½ÃÀÛÆäÀÌÁö |
57 |
³¡ÆäÀÌÁö |
69 |
|
|
÷ºÎ |
|
|
|
¿ä¾à |
In attempt to develop an in vitro assay system of antileprosy drug, fusidic acid and rifampin, we have applied DNA and RT PCR for the detection of M. leprae infection into murine peritoneal macrophages. The evalutation of efficacy of antileprosy drugs and follow-up of MDT were hindered by lack of molecular biological methods to substitute AFB stain, which stains lipid coat of M. leprae could not judge the viability and status of M. leprae proteins, DNA and RNA. Fusidic acid, known as an inhibitor of protein translocation, and rifampin, the most microbicidal agent of MDT components and inhibitor of DNA-dependent RNA polymerase of M. leprae, were injected into M. leprae-infected murine macrophages. Freezing and thawing method reveals most effective way of DNA separation from M. leprae-infected macrophages. Infectivity of M. leprae was confirmed by AFB staining. In spite of successful DNA and RT PCR for the 18 kDa gene of M. leprae, We could not find any difference of bands in agarose gel depending on the concentration and duration of treatments of fusidic acid and rifampin against M. leprae-infected macrophages in vitro. It means that in vitro assays of antileprosy drugs by DNA and RT PCR are so sensitive to detect any bactericidal effects on very slow growing M. leprae. At present, in vitro assay system using DNA and RT PCR appears not eligible to substitute present expensive methods such as [14C-palmitic acid] respirometry with Buddemeyer system or BACTEC 460. It needs further study to settle down as an in vitro assay system to follow up the efficacy of antileprosy drugs such as fusidic acid and rifampin. |
|
|
³»¿ë |
|
| |
¡¡ |
|
|
|
|
|
|
|
|